Promising drug combination may help those with ocular melanoma that ... ( Uveal melanoma affects about 5000 to...)

Promising drug combination may help those with ocular melanoma that has spread

Date:9/4/2007

Uveal melanoma affects about 5,000 to 10,000 people each year in the United States. Unlike its counterpart on the skin, there are no known risk factors, Gollob said.

There are really no truly effective treatments for this devastating disease, he said. So this study really is a promising step toward finding a therapy that can really help these patients.

Uveal melanoma originates in the colored part of the eye, and symptoms include changes in vision, such as blurriness. If found early, it can be treated with radiation or with removal of the eye. When it spreads, uveal melanoma is typically unresponsive to standard treatment regimens, such as chemotherapy, Gollob said. Life expectancy once the disease has spread is about six to ten months, on average, he said.

'/>"/>

Contact: Lauren Shaftel Williams
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. Experimental treatment for Ebola Virus Shows promising results in mice
3. A promising treatment for wart removal
4. Hepatitis shots is promising
5. Promising Treatment for Diabetes
6. Life after Bypass not so Promising for Women.
7. Promising cure for West Nile Virus
8. Deadly Diarrhoea Vaccine – Trail Results Promising
9. Novartis MS Drug Shows Promising Results
10. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
11. Research Ethics Requirements Compromising Quality of Health Research

Post Your Comments:

(Date:12/16/2009)... ANN ARBOR, Mich., Dec. 16 The most widely ... a finding that raises social justice questions that must ... benefit from stem cell advances, according to a University ... study of its kind, the U-M team analyzed 47 ... commonly used by stem cell researchers. The scientists determined ...

(Date:12/16/2009)... HealthSciences Institute will sponsor a new learning ... organizations who serve individuals at risk of, ... health plan, medical home and other provider ... noncommercial webinars on topics, solutions and case ... care improvement. Each webinar will include a ...

(Date:12/16/2009)... seven that increase susceptibility to disease , , WEDNESDAY, ... with increased susceptibility to leprosy have been identified ... researchers, who analyzed more than 10,000 DNA samples ... said their discovery highlights the important role that ... of leprosy. , "Though leprosy is not common, ...

(Date:12/16/2009)... teams led by the Wellcome Trust Sanger Institute announce ... All cancers are caused by mutations in the DNA ... lifetime. The studies, of a malignant melanoma and a ... the mutations in the genomes of two cancers. , ... year: almost all are associated with smoking. The number ...

(Date:12/16/2009)... University of Florida researchers at work on a ... to predict the spread of the disease using cell ... million calls to determine how often residents of Zanzibar ... of two islands off the coast of Tanzania in ... years. Its government commissioned the study as part of ...

Breaking Medicine News(10 mins):Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5 Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2 Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3 Health News:Leprosy Genes Identified 2 Health News:Lung cancer and melanoma laid bare 2 Health News:Lung cancer and melanoma laid bare 3 Health News:Lung cancer and melanoma laid bare 4 Health News:Lung cancer and melanoma laid bare 5 Health News:Lung cancer and melanoma laid bare 6 Health News:Scientists use cell phone records to predict spread of malaria 2 Health News:Scientists use cell phone records to predict spread of malaria 3

[0] U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines [1] New Learning Collaborative to Prepare Clinicians for Better Chronic Care [0] Leprosy Genes Identified [0] Lung cancer and melanoma laid bare [0] Scientists use cell phone records to predict spread of malaria

... the first time, have shown, using a new imaging ... the brain over time. Until now, MRI was used ... key area of the brain for memory and learning. ... larger brain areas. This is the first time a ...

... study published in the British Medical Journal, older people taking ... researchers from Cambridge, UK, identified a group of 2,686 people ... either one capsule of Vitamin D3 or a placebo every ... provide them with information on bone fractures// and any major ...

... and both in developed and developing countries heart disease ... - through premature death and disability. Researchers at the ... measures that could reduce the number of years lost ... could be divided// into non-personal and personal. Non-personal measures ...

... of Pittsburgh researchers are currently testing the safety ... traumatic brain injury. Hypothermia treatment has been shown ... in children, but its effectiveness in treating children ... studied. Hypothermia decreases inflammation, excitotoxicity (excessive neurotransmitters released ...

... now had only an option of a hysterectomy or removal ... fibroid with the drug Mifepristone. Lead researcher Steven H. Eisinger, ... in women and fibroid relief accounts for about 30% of ... have back pain, pain with intercourse, problems with bowels and ...

... stated that there is a metabolic threshold that occurs ... becomes deleterious for lumbar bone mineral density (LBMD) after ... 10-year period, investigated the longitudinal relationship between daily physical ... They assessed LMBD, habitual daily physical activity, total body ...

Other Medicine News:Health News:Treatment for fibroids with "Abortion Pill" 2

New imaging technique for tracking Alzheimer's Lower chance of bone fracture with Vitamin D supplementation Suggestions to reduce global heart disease burden New ways to help children with trauma Treatment for fibroids with "Abortion Pill"Lumbar bone mineral density affected by daily physical activity

(Date:12/16/2009)... MAQUET Cardiovascular LLC, a leading ... it has signed a three-year single source ... supply contracting company, for MAQUET,s market-leading VASOVIEW ... products assist healthcare providers in obtaining veins ... only small incisions. This allows for faster ...

(Date:12/16/2009)... Naurex Inc., a new clinical stage ... CNS disorders based on its novel GFPA NMDA ... a Phase I clinical trial of its lead ... subjects in the study. GLYX-13, a glycine ... the NMDA receptor, is initially being developed as ...

(Date:12/16/2009)... Texas, Dec. 16 Savara, Inc., an inhalation ... the second tranche in its Series A financing round, ... ,, Funds raised in the Series A ... the NanoCluster technology. ,, "We now have the ... performance of the NanoCluster technology," said Rob Neville, CEO ...

Breaking Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4 Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2 Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3 Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2 Solon Manufacturing Company Acquires PurFybr Brands 3B Adds Influenza Virus Diagnostic Swabs to Product Line 12710 1 Solon Manufacturing Company Acquires PurFybr Brands 3B Adds Influenza Virus Diagnostic Swabs to Product Line 12710 2 Pesticide Residue Common on Kitchen Floors 49522 1 Pesticide Residue Common on Kitchen Floors 49522 2 Researchers observe single protein dimers wavering between two symmetrically opposed structures 8934 1 Researchers observe single protein dimers wavering between two symmetrically opposed structures 8934 2 Researchers observe single protein dimers wavering between two symmetrically opposed structures 8934 3 Researchers observe single protein dimers wavering between two symmetrically opposed structures 8934 4

[0] MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices [0] Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression [0] Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent

... Finding May Refine Drug Targets for Personalized Treatments -, ... genes that increase the risk of developing inflammatory,bowel disease ... to identify the specific disease-causing,mutations in these new genes, ... be added to the list of genes already,known to ...

... trial showed prasugrel substantially reduced, risk of heart attack and stent ... ... Germany, Aug. 31 Patients who were,diabetic and diagnosed with acute ... attack if they were treated with prasugrel,vs. clopidogrel, according to a ...

Other Medicine Technology:New Genes Found for Inflammatory Bowel Disease in Children 2 New Genes Found for Inflammatory Bowel Disease in Children 3 New Genes Found for Inflammatory Bowel Disease in Children 4 Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 2 Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 3 Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 4 Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 5

New Genes Found for Inflammatory Bowel Disease in Children Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

Electrophoresis, Protein, Serum Electrolytes, Urine Electrolyte Panel Electrolyte & Osmolality Profile, Fecal

Promising drug combination may help those with ocular melanoma that ...( Uveal melanoma affects about 5000 to...),Health